Connection

DAVID NELSON to Humans

This is a "connection" page, showing publications DAVID NELSON has written about Humans.
Connection Strength

0.492
  1. Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection. Sci Rep. 2022 10 27; 12(1):18094.
    View in: PubMed
    Score: 0.017
  2. Stephen T. Warren: Human geneticist who advanced understanding of mutational mechanisms and developmental disorders. Proc Natl Acad Sci U S A. 2021 08 24; 118(34).
    View in: PubMed
    Score: 0.015
  3. Ectopic expression of CGG-repeats alters ovarian response to gonadotropins and leads to infertility in a murine FMR1 premutation model. Hum Mol Genet. 2021 05 29; 30(10):923-938.
    View in: PubMed
    Score: 0.015
  4. Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C. JAMA Netw Open. 2019 06 05; 2(6):e194765.
    View in: PubMed
    Score: 0.013
  5. 2018 Presidential Address: Who Are We? Am J Hum Genet. 2019 03 07; 104(3):363-372.
    View in: PubMed
    Score: 0.013
  6. Turning the corner from observation to intervention in human genetics. J Genet Genomics. 2018 02 20; 45(2):57-59.
    View in: PubMed
    Score: 0.012
  7. Pragmatic trial of a Study Navigator Model (NAU) vs. Ambassador Model (N+) to increase enrollment to health research among community members who use illicit drugs. Drug Alcohol Depend. 2017 06 01; 175:146-150.
    View in: PubMed
    Score: 0.011
  8. 2016 William Allan Award Introduction: James Gusella. Am J Hum Genet. 2017 Mar 02; 100(3):385-386.
    View in: PubMed
    Score: 0.011
  9. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology. 2015 Apr; 61(4):1127-35.
    View in: PubMed
    Score: 0.010
  10. The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice. Hum Mol Genet. 2015 Apr 15; 24(8):2175-84.
    View in: PubMed
    Score: 0.010
  11. CGG repeats in RNA modulate expression of TDP-43 in mouse and fly models of fragile X tremor ataxia syndrome. Hum Mol Genet. 2014 Nov 15; 23(22):5906-15.
    View in: PubMed
    Score: 0.009
  12. The unstable repeats--three evolving faces of neurological disease. Neuron. 2013 Mar 06; 77(5):825-43.
    View in: PubMed
    Score: 0.009
  13. Subsequent pregnancy outcomes in women previously diagnosed with subclinical hypothyroidism. Am J Perinatol. 2014 Jan; 31(1):77-84.
    View in: PubMed
    Score: 0.009
  14. The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C. Liver Int. 2012 Feb; 32 Suppl 1:103-7.
    View in: PubMed
    Score: 0.008
  15. X-cess of variants in XLMR. Nat Genet. 2009 May; 41(5):510-2.
    View in: PubMed
    Score: 0.007
  16. Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum Mol Genet. 2009 Jul 01; 18(13):2443-51.
    View in: PubMed
    Score: 0.007
  17. Identification and characterization of a repeat-in-toxin gene cluster in Vibrio anguillarum. Infect Immun. 2008 Jun; 76(6):2620-32.
    View in: PubMed
    Score: 0.006
  18. Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Hum Mol Genet. 2007 Oct 01; 16(19):2326-32.
    View in: PubMed
    Score: 0.006
  19. Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation. Am J Med Genet A. 2007 Jun 15; 143A(12):1358-65.
    View in: PubMed
    Score: 0.006
  20. International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety. J Crit Care. 2007 Jun; 22(2):142-52.
    View in: PubMed
    Score: 0.006
  21. NEMO, NFkappaB signaling and incontinentia pigmenti. Curr Opin Genet Dev. 2006 Jun; 16(3):282-8.
    View in: PubMed
    Score: 0.005
  22. Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier? Am J Hum Genet. 2006 Jan; 78(1):125-9.
    View in: PubMed
    Score: 0.005
  23. Genetics. The critical region in trisomy 21. Science. 2004 Oct 22; 306(5696):619-21.
    View in: PubMed
    Score: 0.005
  24. Personal journeys to and in human genetics and dysmorphology. Am J Med Genet A. 2024 06; 194(6):e63514.
    View in: PubMed
    Score: 0.005
  25. The truth about mouse, human, worms and yeast. Hum Genomics. 2004 Jan; 1(2):146-9.
    View in: PubMed
    Score: 0.005
  26. Human genetics. Primate shadow play. Science. 2003 Feb 28; 299(5611):1331-3.
    View in: PubMed
    Score: 0.004
  27. FMR2 function: insight from a mouse knockout model. Cytogenet Genome Res. 2003; 100(1-4):129-39.
    View in: PubMed
    Score: 0.004
  28. Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Genome Res. 2002 Dec; 12(12):1846-53.
    View in: PubMed
    Score: 0.004
  29. The human secretin gene: fine structure in 11p15.5 and sequence variation in patients with autism. Genomics. 2002 Aug; 80(2):185-94.
    View in: PubMed
    Score: 0.004
  30. Identification of PSMB5 as a genetic modifier of fragile X-associated tremor/ataxia syndrome. Proc Natl Acad Sci U S A. 2022 05 31; 119(22):e2118124119.
    View in: PubMed
    Score: 0.004
  31. Complex SNP-based haplotypes in three human helicases: implications for cancer association studies. Genome Res. 2002 Apr; 12(4):627-39.
    View in: PubMed
    Score: 0.004
  32. Physical and genetic characterization reveals a pseudogene, an evolutionary junction, and unstable loci in distal Xq28. Genomics. 2002 Jan; 79(1):31-40.
    View in: PubMed
    Score: 0.004
  33. Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. Genomics. 2001 Dec; 78(3):169-77.
    View in: PubMed
    Score: 0.004
  34. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet. 2001 Sep 15; 10(19):2171-9.
    View in: PubMed
    Score: 0.004
  35. A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. Hepatology. 2021 12; 74(6):2952-2964.
    View in: PubMed
    Score: 0.004
  36. Simultaneous Screening of the FRAXA and FRAXE Loci for Rapid Detection of FMR1 CGG and/or AFF2 CCG Repeat Expansions by Triplet-Primed PCR. J Mol Diagn. 2021 08; 23(8):941-951.
    View in: PubMed
    Score: 0.004
  37. Prevalence and cardiometabolic correlates of ketohexokinase gene variants among UK Biobank participants. PLoS One. 2021; 16(2):e0247683.
    View in: PubMed
    Score: 0.004
  38. SNPs, lonkage disequilibrium, human genetic variation and Native American culture. Trends Genet. 2001 Jan; 17(1):15-6.
    View in: PubMed
    Score: 0.004
  39. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacol Rev. 2021 01; 73(1):310-520.
    View in: PubMed
    Score: 0.004
  40. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium. Am J Hum Genet. 2000 Dec; 67(6):1437-51.
    View in: PubMed
    Score: 0.004
  41. (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet. 2000 May 01; 9(8):1145-59.
    View in: PubMed
    Score: 0.003
  42. Intellectual and developmental disabilities research centers: Fifty years of scientific accomplishments. Ann Neurol. 2019 09; 86(3):332-343.
    View in: PubMed
    Score: 0.003
  43. Alternative splicing in the murine and human FXR1 genes. Genomics. 1999 Jul 15; 59(2):193-202.
    View in: PubMed
    Score: 0.003
  44. Evolution in range expansions with competition at rough boundaries. J Theor Biol. 2019 10 07; 478:153-160.
    View in: PubMed
    Score: 0.003
  45. Cytochrome P450 Monooxygenase CYP139 Family Involved in the Synthesis of Secondary Metabolites in 824 Mycobacterial Species. Int J Mol Sci. 2019 May 31; 20(11).
    View in: PubMed
    Score: 0.003
  46. Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor/ataxia syndrome. Hum Mol Genet. 2019 03 15; 28(6):980-991.
    View in: PubMed
    Score: 0.003
  47. Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy. Nat Commun. 2019 02 15; 10(1):797.
    View in: PubMed
    Score: 0.003
  48. Molecular definition of pericentric inversion breakpoints occurring during the evolution of humans and chimpanzees. Genomics. 1998 Jun 15; 50(3):368-72.
    View in: PubMed
    Score: 0.003
  49. Blooming of Unusual Cytochrome P450s by Tandem Duplication in the Pathogenic Fungus Conidiobolus coronatus. Int J Mol Sci. 2018 06 09; 19(6).
    View in: PubMed
    Score: 0.003
  50. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer. Ann Thorac Surg. 2018 06; 105(6):1671-1677.
    View in: PubMed
    Score: 0.003
  51. Multisite Investigation of Outcomes With?Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2018 01 22; 11(2):181-191.
    View in: PubMed
    Score: 0.003
  52. Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment. N Engl J Med. 2017 10 12; 377(15):1448-1455.
    View in: PubMed
    Score: 0.003
  53. Infant outcomes among women with Zika virus infection?during pregnancy: results of a large prenatal?Zika?screening program. Am J Obstet Gynecol. 2017 Mar; 216(3):292.e1-292.e8.
    View in: PubMed
    Score: 0.003
  54. Selection against mutant alleles in blood leukocytes is a consistent feature in Incontinentia Pigmenti type 2. Hum Mol Genet. 1996 Nov; 5(11):1777-83.
    View in: PubMed
    Score: 0.003
  55. Impact of metabolic acidemia at birth on neonatal outcomes in infants born before 34 weeks' gestation. J Matern Fetal Neonatal Med. 2017 Aug; 30(16):1902-1905.
    View in: PubMed
    Score: 0.003
  56. Genetic variation and evolutionary stability of the FMR1 CGG repeat in six closed human populations. Am J Med Genet. 1996 Jul 12; 64(1):220-5.
    View in: PubMed
    Score: 0.003
  57. Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution. Hum Mol Genet. 1996 Jul; 5(7):899-912.
    View in: PubMed
    Score: 0.003
  58. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet. 1996 May; 13(1):109-13.
    View in: PubMed
    Score: 0.003
  59. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome. Hum Mol Genet. 1996 Mar; 5(3):319-30.
    View in: PubMed
    Score: 0.003
  60. Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network. Liver Transpl. 2016 Jan; 22(1):24-33.
    View in: PubMed
    Score: 0.003
  61. Population survey of the human FMR1 CGG repeat substructure suggests biased polarity for the loss of AGG interruptions. Hum Mol Genet. 1995 Dec; 4(12):2199-208.
    View in: PubMed
    Score: 0.003
  62. A muscle-specific DNase I-like gene in human Xq28. Hum Mol Genet. 1995 Sep; 4(9):1557-64.
    View in: PubMed
    Score: 0.003
  63. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome. Nat Genet. 1995 Aug; 10(4):483-5.
    View in: PubMed
    Score: 0.003
  64. An analysis of population-based prenatal screening for overt hypothyroidism. Am J Obstet Gynecol. 2015 Oct; 213(4):565.e1-6.
    View in: PubMed
    Score: 0.003
  65. Positional cloning reaches maturity. Curr Opin Genet Dev. 1995 Jun; 5(3):298-303.
    View in: PubMed
    Score: 0.002
  66. The fragile X syndromes. Semin Cell Biol. 1995 Feb; 6(1):5-11.
    View in: PubMed
    Score: 0.002
  67. The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome. Cell Cycle. 2015; 14(18):2985-95.
    View in: PubMed
    Score: 0.002
  68. De novo mutation in three families with multigenerational incontinentia pigmenti. Am J Hum Genet. 1994 Dec; 55(6):1279-81.
    View in: PubMed
    Score: 0.002
  69. Origin of the response to adrenal and sex steroids: Roles of promiscuity and co-evolution of enzymes and steroid receptors. J Steroid Biochem Mol Biol. 2015 Jul; 151:12-24.
    View in: PubMed
    Score: 0.002
  70. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet. 1994 Nov; 8(3):229-35.
    View in: PubMed
    Score: 0.002
  71. MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes. Eur J Hum Genet. 2015 Jun; 23(6):781-9.
    View in: PubMed
    Score: 0.002
  72. A de novo deletion in FMR1 in a patient with developmental delay. Hum Mol Genet. 1994 Sep; 3(9):1705-6.
    View in: PubMed
    Score: 0.002
  73. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet. 1994 Sep; 8(1):88-94.
    View in: PubMed
    Score: 0.002
  74. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med. 2014 Apr 24; 370(17):1594-603.
    View in: PubMed
    Score: 0.002
  75. Fine structure of the human FMR1 gene. Hum Mol Genet. 1994 Apr; 3(4):684-5.
    View in: PubMed
    Score: 0.002
  76. Frequency and stability of the fragile X premutation. Hum Mol Genet. 1994 Mar; 3(3):393-8.
    View in: PubMed
    Score: 0.002
  77. Advances in molecular analysis of fragile X syndrome. JAMA. 1994 Feb 16; 271(7):536-42.
    View in: PubMed
    Score: 0.002
  78. Regional assignment of 19 X-linked ESTs. Hum Mol Genet. 1993 Nov; 2(11):1901-5.
    View in: PubMed
    Score: 0.002
  79. Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of fragile X-associated tremor/ataxia syndrome. Hum Mol Genet. 2014 Feb 15; 23(4):1095-107.
    View in: PubMed
    Score: 0.002
  80. Trinucleotide repeat expansions in neurological disease. Curr Opin Neurobiol. 1993 Oct; 3(5):752-9.
    View in: PubMed
    Score: 0.002
  81. Alternative splicing in the fragile X gene FMR1. Hum Mol Genet. 1993 Aug; 2(8):1348.
    View in: PubMed
    Score: 0.002
  82. Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States. BMC Geriatr. 2013 Jul 16; 13:74.
    View in: PubMed
    Score: 0.002
  83. Trinucleotide repeat instability: when and where? Nat Genet. 1993 Jun; 4(2):107-8.
    View in: PubMed
    Score: 0.002
  84. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci U S A. 2013 May 07; 110(19):7778-83.
    View in: PubMed
    Score: 0.002
  85. Methods for finding genes. A major rate-limiting step in positional cloning. Genet Anal Tech Appl. 1993 Apr; 10(2):29-41.
    View in: PubMed
    Score: 0.002
  86. Alternative splicing in the fragile X gene FMR1. Hum Mol Genet. 1993 Apr; 2(4):399-404.
    View in: PubMed
    Score: 0.002
  87. CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant. Liver Int. 2013 Jan; 33(1):72-8.
    View in: PubMed
    Score: 0.002
  88. Sonographic findings in two cases of complicated pregnancy in women previously treated with endometrial ablation. J Clin Ultrasound. 2013 Nov-Dec; 41(9):566-9.
    View in: PubMed
    Score: 0.002
  89. Triplet repeat mutations in human disease. Science. 1992 May 08; 256(5058):784-9.
    View in: PubMed
    Score: 0.002
  90. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012 Aug; 14(8):729-36.
    View in: PubMed
    Score: 0.002
  91. Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila. Hum Mol Genet. 2012 May 01; 21(9):2068-75.
    View in: PubMed
    Score: 0.002
  92. FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124. J Neurosci. 2011 Sep 28; 31(39):13705-9.
    View in: PubMed
    Score: 0.002
  93. Retrotransposon activation contributes to fragile X premutation rCGG-mediated neurodegeneration. Hum Mol Genet. 2012 Jan 01; 21(1):57-65.
    View in: PubMed
    Score: 0.002
  94. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells. Virol J. 2011 Sep 21; 8:445.
    View in: PubMed
    Score: 0.002
  95. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991 Aug 23; 66(4):817-22.
    View in: PubMed
    Score: 0.002
  96. Alu-primed polymerase chain reaction for regional assignment of 110 yeast artificial chromosome clones from the human X chromosome: identification of clones associated with a disease locus. Proc Natl Acad Sci U S A. 1991 Jul 15; 88(14):6157-61.
    View in: PubMed
    Score: 0.002
  97. Desmoplakin and talin2 are novel mRNA targets of fragile X-related protein-1 in cardiac muscle. Circ Res. 2011 Jul 22; 109(3):262-71.
    View in: PubMed
    Score: 0.002
  98. Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning. Nat Med. 2011 May; 17(5):559-65.
    View in: PubMed
    Score: 0.002
  99. Site-specific phosphorylation of the middle molecular weight human neurofilament protein in transfected non-neuronal cells. J Neurosci. 1990 Jul; 10(7):2428-37.
    View in: PubMed
    Score: 0.002
  100. Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. Proc Natl Acad Sci U S A. 1989 Sep; 86(17):6686-90.
    View in: PubMed
    Score: 0.002
  101. Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene. Behav Neurosci. 2008 Dec; 122(6):1371-7.
    View in: PubMed
    Score: 0.002
  102. Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene. Behav Neurosci. 2008 Jun; 122(3):710-5.
    View in: PubMed
    Score: 0.002
  103. The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J. 1987 Jun; 6(6):1617-26.
    View in: PubMed
    Score: 0.001
  104. Process of care and outcomes in patients with peripheral arterial disease. J Gen Intern Med. 2007 Jul; 22(7):942-8.
    View in: PubMed
    Score: 0.001
  105. Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study. J Hepatol. 2007 Jul; 47(1):51-9.
    View in: PubMed
    Score: 0.001
  106. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res. 2007 Jan 15; 313(2):244-53.
    View in: PubMed
    Score: 0.001
  107. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes. Exp Neurol. 2007 Jan; 203(1):233-40.
    View in: PubMed
    Score: 0.001
  108. The finished DNA sequence of human chromosome 12. Nature. 2006 03 16; 440(7082):346-51.
    View in: PubMed
    Score: 0.001
  109. Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med. 2006 Mar 13; 166(5):536-42.
    View in: PubMed
    Score: 0.001
  110. Gene replacement therapy for inborn errors of purine metabolism. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:1065-71.
    View in: PubMed
    Score: 0.001
  111. Positive selection of a pre-expansion CAG repeat of the human SCA2 gene. PLoS Genet. 2005 Sep; 1(3):e41.
    View in: PubMed
    Score: 0.001
  112. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J. 2005 Sep 07; 2:80.
    View in: PubMed
    Score: 0.001
  113. Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance. J Interferon Cytokine Res. 2005 Sep; 25(9):528-39.
    View in: PubMed
    Score: 0.001
  114. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron. 2005 Aug 04; 47(3):339-52.
    View in: PubMed
    Score: 0.001
  115. The DNA sequence of the human X chromosome. Nature. 2005 Mar 17; 434(7031):325-37.
    View in: PubMed
    Score: 0.001
  116. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet. 1994 Jul 15; 51(4):298-308.
    View in: PubMed
    Score: 0.001
  117. Somatic and germline instability of the ATTCT repeat in spinocerebellar ataxia type 10. Am J Hum Genet. 2004 Jun; 74(6):1216-24.
    View in: PubMed
    Score: 0.001
  118. Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis. Lab Invest. 2004 Mar; 84(3):332-41.
    View in: PubMed
    Score: 0.001
  119. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci. 2004 Feb; 7(2):113-7.
    View in: PubMed
    Score: 0.001
  120. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology. 2003 May; 37(5):1180-8.
    View in: PubMed
    Score: 0.001
  121. Cytogenetic analysis of obsessive-compulsive disorder (OCD): identification of a FRAXE fragile site. Am J Med Genet A. 2003 Apr 01; 118A(1):25-8.
    View in: PubMed
    Score: 0.001
  122. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991 Dec 20; 67(6):1047-58.
    View in: PubMed
    Score: 0.001
  123. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum Mol Genet. 2001 Oct 15; 10(22):2557-67.
    View in: PubMed
    Score: 0.001
  124. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31; 65(5):905-14.
    View in: PubMed
    Score: 0.001
  125. Initial sequencing and analysis of the human genome. Nature. 2001 Feb 15; 409(6822):860-921.
    View in: PubMed
    Score: 0.001
  126. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet. 2001 Mar; 68(3):765-71.
    View in: PubMed
    Score: 0.001
  127. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2000 Oct; 26(2):191-4.
    View in: PubMed
    Score: 0.001
  128. Filamin (FLN1), plexin (SEX), major palmitoylated protein p55 (MPP1), and von-Hippel Lindau binding protein (VBP1) are not involved in incontinentia pigmenti type 2. Am J Med Genet. 2000 Sep 04; 94(1):79-84.
    View in: PubMed
    Score: 0.001
  129. The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins. Hum Mol Genet. 2000 Jun 12; 9(10):1487-93.
    View in: PubMed
    Score: 0.001
  130. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000 May 25; 405(6785):466-72.
    View in: PubMed
    Score: 0.001
  131. Proposal for a human genome evolution project. Mol Phylogenet Evol. 2000 Apr; 15(1):1-4.
    View in: PubMed
    Score: 0.001
  132. Human homologue of the murine bare patches/striated gene is not mutated in incontinentia pigmenti type 2. Am J Med Genet. 2000 Mar 20; 91(3):241-4.
    View in: PubMed
    Score: 0.001
  133. Mutation analysis of the DKC1 gene in incontinentia pigmenti. J Med Genet. 1999 Nov; 36(11):860-2.
    View in: PubMed
    Score: 0.001
  134. Reduced mRNA for G3BP in fragile X cells: evidence of FMR1 gene regulation. Am J Med Genet. 1999 May 28; 84(3):268-71.
    View in: PubMed
    Score: 0.001
  135. Re-examination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism in FMR1. Hum Mol Genet. 1998 Nov; 7(12):1935-46.
    View in: PubMed
    Score: 0.001
  136. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A. 1998 Sep 29; 95(20):11751-6.
    View in: PubMed
    Score: 0.001
  137. MSG1 (melanocyte-specific gene 1): mapping to chromosome Xq13.1, genomic organization, and promoter analysis. Genomics. 1998 Aug 01; 51(3):401-7.
    View in: PubMed
    Score: 0.001
  138. Interruptions in the triplet repeats of SCA1 and FRAXA reduce the propensity and complexity of slipped strand DNA (S-DNA) formation. Biochemistry. 1998 Feb 24; 37(8):2701-8.
    View in: PubMed
    Score: 0.001
  139. X-linked situs abnormalities result from mutations in ZIC3. Nat Genet. 1997 Nov; 17(3):305-8.
    View in: PubMed
    Score: 0.001
  140. Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. Hum Mol Genet. 1997 Jul; 6(7):991-1002.
    View in: PubMed
    Score: 0.001
  141. Molecular and phenotypic variation in patients with severe Hunter syndrome. Hum Mol Genet. 1997 Mar; 6(3):479-86.
    View in: PubMed
    Score: 0.001
  142. Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype. Am J Hum Genet. 1997 Jan; 60(1):103-12.
    View in: PubMed
    Score: 0.001
  143. A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. Genomics. 1997 Jan 01; 39(1):55-65.
    View in: PubMed
    Score: 0.001
  144. Large domains of apparent delayed replication timing associated with triplet repeat expansion at FRAXA and FRAXE. Am J Hum Genet. 1996 Aug; 59(2):407-16.
    View in: PubMed
    Score: 0.001
  145. FMR1 in global populations. Am J Hum Genet. 1996 Mar; 58(3):513-22.
    View in: PubMed
    Score: 0.001
  146. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics. 1996 Jan; 97(1):122-6.
    View in: PubMed
    Score: 0.001
  147. Anomalous rapid electrophoretic mobility of DNA containing triplet repeats associated with human disease genes. Biochemistry. 1995 Dec 12; 34(49):16125-31.
    View in: PubMed
    Score: 0.001
  148. Gonadal mosaicism for incontinentia pigmenti in a healthy male. J Med Genet. 1995 Nov; 32(11):887-90.
    View in: PubMed
    Score: 0.001
  149. 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus. Genome Res. 1995 Aug; 5(1):71-8.
    View in: PubMed
    Score: 0.001
  150. Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits. J Cell Biol. 1995 Jun; 129(6):1629-40.
    View in: PubMed
    Score: 0.001
  151. An n-allele model for progressive amplification in the FMR1 locus. Proc Natl Acad Sci U S A. 1995 May 23; 92(11):4833-7.
    View in: PubMed
    Score: 0.001
  152. The fragile X premutation in carriers and its effect on mutation size in offspring. Am J Hum Genet. 1995 May; 56(5):1147-55.
    View in: PubMed
    Score: 0.001
  153. The gene encoding the VP16-accessory protein HCF (HCFC1) resides in human Xq28 and is highly expressed in fetal tissues and the adult kidney. Genomics. 1995 Jan 20; 25(2):462-8.
    View in: PubMed
    Score: 0.001
  154. Fragile X syndrome in a normal IQ male with learning and emotional problems. J Am Acad Child Adolesc Psychiatry. 1994 Nov-Dec; 33(9):1316-21.
    View in: PubMed
    Score: 0.001
  155. Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes. Hum Mol Genet. 1994 Oct; 3(10):1823-7.
    View in: PubMed
    Score: 0.001
  156. Reliability of diagnostic assessment of normal and premutation status in the fragile X syndrome using DNA testing. Am J Med Genet. 1994 Jul 15; 51(4):339-45.
    View in: PubMed
    Score: 0.001
  157. Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase. Am J Med Genet. 1994 Jul 15; 51(4):522-6.
    View in: PubMed
    Score: 0.001
  158. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet. 1993 Oct; 2(10):1659-65.
    View in: PubMed
    Score: 0.001
  159. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet. 1993 Jul; 4(3):244-51.
    View in: PubMed
    Score: 0.001
  160. High-resolution mapping of probes near the X-linked lymphoproliferative disease (XLP) locus. Genomics. 1993 Jul; 17(1):163-70.
    View in: PubMed
    Score: 0.001
  161. Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. Genomics. 1993 Apr; 16(1):254-5.
    View in: PubMed
    Score: 0.001
  162. Direct versus indirect molecular diagnosis of fragile X mental retardation in 40 German families at risk. J Med Genet. 1993 Mar; 30(3):193-7.
    View in: PubMed
    Score: 0.001
  163. Physical mapping of Xq24-25 around loci closely linked to the X-linked lymphoproliferative syndrome locus: an overlapping YAC map and linkage between DXS12, DXS42, and DXS37. Eur J Hum Genet. 1993; 1(1):64-71.
    View in: PubMed
    Score: 0.001
  164. Report and abstracts of the Fourth International Workshop on Human X Chromosome Mapping 1993. St. Louis, Missouri, May 9-12, 1993. Cytogenet Cell Genet. 1993; 64(3-4):147-94.
    View in: PubMed
    Score: 0.001
  165. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet. 1993 Jan; 3(1):36-43.
    View in: PubMed
    Score: 0.001
  166. Frequent small amplifications in the FMR-1 gene in fra(X) families: limits to the diagnosis of 'premutations'. J Med Genet. 1992 Nov; 29(11):802-6.
    View in: PubMed
    Score: 0.001
  167. Genome analysis and the human X chromosome. Science. 1992 Oct 02; 258(5079):103-9.
    View in: PubMed
    Score: 0.001
  168. Cloning of human and bovine homologs of SNF2/SWI2: a global activator of transcription in yeast S. cerevisiae. Nucleic Acids Res. 1992 Sep 11; 20(17):4649-55.
    View in: PubMed
    Score: 0.001
  169. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992 Sep; 1(6):397-400.
    View in: PubMed
    Score: 0.001
  170. PCR amplification and analysis of yeast artificial chromosomes. Genomics. 1992 Aug; 13(4):1303-6.
    View in: PubMed
    Score: 0.001
  171. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature. 1992 Jul 16; 358(6383):239-42.
    View in: PubMed
    Score: 0.001
  172. Intragenic probe used for diagnostics in fragile X families. Am J Med Genet. 1992 Apr 15-May 1; 43(1-2):192-6.
    View in: PubMed
    Score: 0.000
  173. Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site. Am J Med Genet. 1992 Apr 15-May 1; 43(1-2):237-43.
    View in: PubMed
    Score: 0.000
  174. Isolation of cDNA sequences around the chromosomal breakpoint in a female with Lowe syndrome by direct screening of cDNA libraries with yeast artificial chromosomes. J Inherit Metab Dis. 1992; 15(4):526-31.
    View in: PubMed
    Score: 0.000
  175. Direct cloning of human transcripts with HnRNA from hybrid cell lines. Science. 1990 Aug 10; 249(4969):652-5.
    View in: PubMed
    Score: 0.000
  176. Report of the X chromosome workshop. Genomics. 1990 Aug; 7(4):647-54.
    View in: PubMed
    Score: 0.000
  177. The large DNA insert cloning workshop. Genomics. 1990 Aug; 7(4):654-60.
    View in: PubMed
    Score: 0.000
  178. Rapid isolation of DNA probes within specific chromosome regions by interspersed repetitive sequence polymerase chain reaction. Genomics. 1990 Mar; 6(3):475-81.
    View in: PubMed
    Score: 0.000
  179. Expression and regulation of human low-density lipoprotein receptors in Chinese hamster ovary cells. Nature. 1984 Feb 23-29; 307(5953):742-5.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.